STK11 and cancer: Since little is understood about the complex interplay between LKB1 and oncogenes in breast cancer, we evaluated the expression of LKB1 in human breast cancer tissue microarrays and found that 31% of HER2 positive highly invasive cancers were null for LKB1 expression.